Proper activation of the mTOR pathway increases the expression of oncogenes, and pathway inhibition may cause downregulation of certain oncogenes' expression levels, and at the same time activate other oncogenes through the cross-talk pathway to cause tumor progression. This evidence concerns the gene MTOR and neoplasm.